Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences
(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.
Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.
This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.
read more
Evofem Biosciences Names Albert Altro As Interim CFO
Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews
|
601 dagar sedan
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria
Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews
|
755 dagar sedan
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi
Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews
|
855 dagar sedan
Canadian Market Slightly Lower In Cautious Trade
Canadian stocks are turning in a mixed performance on Wednesday with investors largely reacting to earnings announcements, and U.S. economic data.
Materials stocks are among the notable losers, while consumer staples and utilities shares are finding good support.
RTTNews
|
4h 33minuter sedan
German Inflation Climbs More Than Expected Dampening Bigger Rate Cut Hopes
Consumer price inflation in Germany increased more than expected to its highest level in three months in October and the core figure moved closer to 3 percent, damping expectations for a bigger size interest rate cut from the European Central Bank.
RTTNews
|
5h 1minuter sedan
Swiss Market Ends Notably Lower
The Switzerland market ended notably lower on Wednesday after languishing in negative territory right through the day's session, as investors reacted to weak economic data, digested a slew of corporate earnings announcements, and looked ahead to some key U.S. economic data due later in the week.
RTTNews
|
5h 19minuter sedan
U.S. Dollar Retreats As GDP Growth Slows
The U.S. dollar pulled back against its major counterparts in the New York session on Wednesday, as a slowdown in GDP growth outweighed optimism about strong ADP data.
RTTNews
|
5h 31minuter sedan
European Stocks Close Lower As Investors React To Economic Data, Earnings Updates
European stocks closed weak on Wednesday, with investors reacting to a slew of economic data from the region, the UK budget, and corporate earnings updates, in addition to closely tracking U.S. economic data and following the developments on the geopolitical front.
RTTNews
|
5h 36minuter sedan
